The presence of ESR1 mutations in ctDNA of advanced BC patients showed a worse PFS compared with those with the ESR1 wild type (HR = 1.46, p = 0.02) [20], and were highly associated with shorter OS (OR = 0.36) [143]. Here, ESR1 is linked to breast cancer.